Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Iowa Tech Report.
Press releases published on April 15, 2025
Digital Marketing, Solved: AgencyBloc Launches Engage+ Built with Real Agent Input
EIN Presswire
·
April 15, 2025
Built for health, senior and benefits agencies, Engage+ simplifies digital marketing with semi-custom websites, ready-made tools, and expert content CEDAR FALLS, IA, UNITED STATES, April 15, 2025 /EINPresswire.com/ -- AgencyBloc, a leading provider of …
Leqembi®∇ (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union
GlobeNewswire
·
April 15, 2025
In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild dementia due to Alzheimer’s disease (early AD) who are apolipoprotein E ε4 (ApoE ε4*) non-carriers or …
PrimeEnergy Resources Corporation (PNRG) Announces Yearend Production and Financial Results
GlobeNewswire
·
April 15, 2025
HOUSTON, April 15, 2025 (GLOBE NEWSWIRE) -- The following table summarizes the primary components of production volumes and average sales prices realized for the years ended December 31, 2024 and 2023 (excluding realized gains and losses from derivatives …
Deal Box and OroBit Make Bitcoin the Foundation for Secure Asset Tokenization, Targeting $30 Trillion Market
GlobeNewswire
·
April 15, 2025
Carlsbad, CA, April 15, 2025 (GLOBE NEWSWIRE) -- Carlsbad, CA – April 15, 2025 – Deal Box, a leading digital securities investment platform, and OroBit, an innovative Bitcoin Layer-2 entity, today announced a strategic initiative aimed at the rapidly …
Theratechnologies fait le point sur le processus de vente
GlobeNewswire
·
April 15, 2025
MONTRÉAL, 15 avr. 2025 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique au stade commercial, annonce aujourd’hui qu’après un examen attentif des circonstances …
Radiance Announces First Patient Dosing in Phase 1 Clinical Trial of its Next Generation ROR-1 Targeted ADC for Hematologic and Solid Malignancies
GlobeNewswire
·
April 15, 2025
BOSTON, April 15, 2025 (GLOBE NEWSWIRE) -- Radiance Biopharma, Inc. (“Radiance” or the “Company”), a clinical stage biopharmaceutical company advancing Antibody Drug Conjugates (‘ADCs’), today announced that the first patient in China has been dosed in the …
Synaptics to Report Third Quarter Fiscal 2025 Results on May 8, 2025
GlobeNewswire
·
April 15, 2025
SAN JOSE, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: SYNA) today announced that it will report financial results for the third quarter of fiscal 2025 on Thursday, May 8, 2025, after the market closes. The Company will host …
Stride Announces Date for Third Quarter Fiscal Year 2025 Earnings Call
GlobeNewswire
·
April 15, 2025
RESTON, VA, April 15, 2025 (GLOBE NEWSWIRE) -- Stride Inc. (NYSE: LRN) announced today it plans to discuss its third quarter fiscal year 2025 financial results during a conference call scheduled for Tuesday, April 29, 2025 at 5:00 p.m. eastern time (ET). …
Intermap Presenting at the Planet MicroCap Showcase on April 23, 2025
GlobeNewswire
·
April 15, 2025
DENVER, April 15, 2025 (GLOBE NEWSWIRE) -- Intermap Technologies (TSX: IMP; OTCQB: ITMSF) (“Intermap” or the “Company”), a global leader in 3D geospatial products and intelligence solutions, today announced that its Chairman and CEO, Patrick A. Blott, …
2025 Cryptocurrency RICH MINER Complete Guide: From Novice to Profitable Freedom
GlobeNewswire
·
April 15, 2025
London, UK, April 15, 2025 (GLOBE NEWSWIRE) -- In 2025, when the cryptocurrency market is becoming more volatile, investors' demand for stability, security and sustainable returns has reached a new high. Rich Miner was named "Best Cloud Mining Platform of …
Banzai Reports Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire
·
April 15, 2025
Revenue of $16.7 Million on a Consolidated, Pro-forma Basis for the Twelve Months Ending December 31, 2024, Representing 267% Annual Growth; Exceeded Guidance of $10 Million by 67% Q4 2024 Adjusted Net Loss Improved by $7.8 Million from ($9.2) Million in …
可靈AI全系模型進入2.0時代 讓每個人都能用AI講出好故事
GlobeNewswire
·
April 15, 2025
香港, April 16, 2025 (GLOBE NEWSWIRE) -- 領先的內容社區及社交平台快手科技（「快手」或「公司」；港幣櫃台股份代號：01024 / 人民幣櫃台股份代號：81024）宣佈，可靈AI在北京舉行「靈感成真」2.0模型發佈會，宣佈基座模型再次升級，面向全球正式發佈可靈2.0視頻生成模型及可圖2.0圖像生成模型。 作為全球首個用戶可用的DiT視頻生成模型，可靈AI自去年6月上線至今的10個月時間裡，全球用戶規模已突破2,200萬。3月27日，全球知名AI基準測試機構 …
Mercury Systems to Report Third Quarter Fiscal Year 2025 Financial Results on May 6, 2025
GlobeNewswire
·
April 15, 2025
ANDOVER, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- Mercury Systems Inc. (NASDAQ: MRCY, www.mrcy.com), a technology company that delivers mission-critical processing power to the edge, will release its third quarter fiscal year 2025 financial results after …
Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 15, 2025
SAN DIEGO, April 15, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that on April 14, 2025, non- …
Diginex Limited and AIKYA Announce Strategic Alliance to Launch diginexESG in Malaysia, Advancing ESG Reporting and Sustainable Finance
GlobeNewswire
·
April 15, 2025
LONDON, April 15, 2025 (GLOBE NEWSWIRE) -- Diginex Limited (“Diginex”) (NASDAQ: DGNX), a leading impact technology company specializing in environmental, social, and governance (“ESG”) solutions, today announced a strategic alliance with AIKYA, a leading …
Sernova Biotherapeutics Cell Pouch Bio-hybrid Organ to be Highlighted at Cell & Gene Meeting on the Med
GlobeNewswire
·
April 15, 2025
LONDON, Ontario and BOSTON, April 15, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company, today announced that the Company’s Cell Pouch Bio-hybrid Organ in clinical …
NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board
GlobeNewswire
·
April 15, 2025
BOSTON, April 15, 2025 (GLOBE NEWSWIRE) -- NeuroNOS, a biopharmaceutical company focused on developing transformative treatments for Autism Spectrum Disorder (ASD) and Alzheimer’s disease (AD)conditions, and a subsidiary of Beyond Air (NASDAQ: XAIR), is …
Cardiff Oncology Announces Completion of Enrollment in Phase 2 CRDF-004 Trial Evaluating Onvansertib for the Treatment of First-line RAS-mutated Metastatic Colorectal Cancer
GlobeNewswire
·
April 15, 2025
- Initial results from randomized Phase 2 CRDF-004 trial in RAS-mut mCRC were released in December 2024 - - Additional clinical data from CRDF-004 trial expected in 1H 2025 - SAN DIEGO, April 15, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: …
Century Therapeutics to Host Live Fireside Chat Focused on Newly Prioritized Preclinical Cell Therapy Programs for Autoimmune Diseases and Cancer on Tuesday, April 22, 2025
GlobeNewswire
·
April 15, 2025
PHILADELPHIA, April 15, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in autoimmune disease and cancer, today …
Inventiva annonce le dépôt de son Document d’Enregistrement Universel 2024 et de son Rapport Annuel 2024 (« Form 20-F »)
GlobeNewswire
·
April 15, 2025
Daix (France), New York City (New York, États-Unis), le 15 avril 2025 - Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement clinique de petites molécules administrées par …